Delbeke F T, Debackere M
Laboratorium voor Farmacologie en Toxicologie der Huisdieren, Faculteit Diergeneeskunde, Rijksuniversiteti Gent, Belgium.
Biopharm Drug Dispos. 1988 Mar-Apr;9(2):137-45. doi: 10.1002/bod.2510090203.
The urinary excretion of caffeine in humans was followed over a period of 36 h after the oral administration of ANIMINE, a formulation containing caffeine-alpha-naphthylacetate. The excretion of caffeine was not as markedly affected by the urinary pH as was found with stimulant amines. Excretion peaks were obtained 1-2 h after the ingestion and the total amount of unchanged caffeine excreted during 12 h varied from 0.57 to 1.51 per cent. The ingestion of the diuretics acetazolamide or furosemide 2 h after caffeine resulted in a urine-flow dependent and consequently increased caffeine excretion during 2-4 h post-diuretic. This increase paralleled the increase in urine volume resulting in no meaningful differences in caffeine concentration compared to normal conditions.
在口服含有咖啡因-α-萘乙酸酯的制剂ANIMINE后,对人体咖啡因的尿排泄情况进行了36小时的跟踪研究。与刺激性胺类物质不同,咖啡因的排泄受尿液pH值的影响并不明显。摄入后1 - 2小时出现排泄峰值,12小时内排泄的未变化咖啡因总量在0.57%至1.51%之间。在摄入咖啡因2小时后服用利尿剂乙酰唑胺或呋塞米,会导致利尿后2 - 4小时内尿量依赖性增加,进而使咖啡因排泄增加。这种增加与尿量增加平行,与正常情况相比,咖啡因浓度没有显著差异。